A programmed switch from IL-15- to IL-2-dependent activation in human NK cells

Journal of Immunology

Volumn 182, Issue 10, 2009, Pages 6267-6277

  Pillet, Anne Hélène ^a   Bugault, Florence ^a   Thèze, Jacques ^a   Chakrabarti, Lisa A ^a   Rose, Thierry ^a  

^a INSTITUT PASTEUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; CYTOKINE RECEPTOR; GAMMA INTERFERON; INTERLEUKIN 15; INTERLEUKIN 15 RECEPTOR; INTERLEUKIN 15 RECEPTOR ALPHA; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 5; INTERLEUKIN 7; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 1; STAT5 PROTEIN;

ARTICLE; BINDING AFFINITY; CYTOKINE RELEASE; HUMAN; NATURAL KILLER CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; STIMULATION;

BLOTTING, WESTERN; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; HUMANS; IMMUNOPRECIPITATION; INTERFERON-GAMMA; INTERLEUKIN-15; INTERLEUKIN-2; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION; LYSOSOMAL-ASSOCIATED MEMBRANE PROTEIN 1; PHOSPHORYLATION; RECEPTORS, CYTOKINE; STAT5 TRANSCRIPTION FACTOR;

EID: 71749113283     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0801933     Document Type: Article

References (58)

1. Trinchieri, G. 1989. Biology of natural killer cells. Adv. Immunol. 47: 187-376.
2. Becknell, B., and M. A. Caligiuri. 2005. Interleukin-2, interleukin-15, and their roles in human natural killer cells. Adv. Immunol. 86: 209-239. (Pubitemid 40215694)
3. Vivier, E., E. Tomasello, M. Baratin, T. Walzer, and S. Ugolini. 2008. Functions of natural killer cells. Nat. Immunol. 9: 503-510.
4. Moretta, L., C. Bottino, D. Pende, R. Castriconi, M. C. Mingari, and A. Moretta. 2006. Surface NK receptors and their ligands on tumor cells. Semin. Immunol. 18: 151-158. (Pubitemid 43817561)
5. Cooper, M. A., T. A. Fehniger, and M. A. Caligiuri. 2001. The biology of human natural killer-cell subsets. Trends Immunol. 22: 633-640.
6. Walzer, T., M. Dalod, S. H. Robbins, L. Zitvogel, and E. Vivier. 2005. Natural-killer cells and dendritic cells: "l'union fait la force." Blood 106: 2252-2258.
7. Moretta, A., E. Marcenaro, S. Sivori, M. Della Chiesa, M. Vitale, and L. Moretta. 2005. Early liaisons between cells of the innate immune system in inflamed peripheral tissues. Trends Immunol. 26: 668-675. (Pubitemid 41628200)
8. + T cell subsets and induces early resistance to Leishmania major in mice. J. Exp. Med. 178: 567-577.
9. Waldmann, T. A. 2006. The biology of interleukin-2 and interleukin-15: implications for cancer therapy and vaccine design. Nat. Rev. 6: 595-601. (Pubitemid 44134092)
10. Ma, A., R. Koka, and P. Burkett. 2006. Diverse functions of IL-2, IL-15, and IL-7 in lymphoid homeostasis. Annu. Rev. Immunol. 24: 657-679.
11. Leclercq, G., V. Debacker, M. de Smedt, and J. Plum. 1996. Differential effects of interleukin-15 and interleukin-2 on differentiation of bipotential T/natural killer progenitor cells. J. Exp. Med. 184: 325-336. (Pubitemid 26324086)
12. Carson, W. E., J. G. Giri, M. J. Lindemann, M. L. Linett, M. Ahdieh, R. Paxton, D. Anderson, J. Eisenmann, K. Grabstein, and M. A. Caligiuri. 1994. Interleukin (IL) 15 is a novel cytokine that activates human natural killer cells via components of the IL-2 receptor. J. Exp. Med. 180: 1395-1403.
13. + hematopoietic progenitor cells. Blood 87: 2632-2640.
14. Carson, W. E., T. A. Fehniger, S. Haldar, K. Eckhert, M. J. Lindemann, C. F. Lai, C. M. Croce, H. Baumann, and M. A. Caligiuri. 1997. A potential role for interleukin- 15 in the regulation of human natural killer cell survival. J. Clin. Invest. 99: 937-943.
15. Bulfone-Pau, S. S., E. Bulanova, T. Pohl, V. Budagian, H. Durkop, R. Ruckert, U. Kunzendorf, R. Paus, and H. Krause. 1999. Death deflected: IL-15 inhibits TNF-α-mediated apoptosis in fibroblasts by TRAF2 recruitment to the IL-15Rα chain. FASEB J. 13: 1575-1585.
16. Pereno, R., J. Giron-Michel, A. Gaggero, E. Cazes, R. Meazza, M. Monetti, E. Monaco, Z. Mishal, C. Jasmin, F. Indiveri, et al. 2000. IL-15/IL-15Rα intracellular trafficking in human melanoma cells and signal transduction through the IL-15Rα. Oncogene 19: 5153-5162.
17. Budagian, V., E. Bulanova, R. Paus, and S. Bulfone-Paus. 2006. IL-15/IL-15 receptor biology: a guided tour through an expanding universe. Cytokine Growth Factor Rev. 17: 259-280. (Pubitemid 44038618)
18. Chirifu, M., C. Hayashi, T. Nakamura, S. Toma, T. Shuto, H. Kai, Y. Yamagata, S. J. Davis, and S. Ikemizu. 2007. Crystal structure of the IL-15-IL-15Rα complex, a cytokine-receptor unit presented in trans. Nat. Immunol. 8: 1001-1007. (Pubitemid 47300015)
19. Dubois, S., J. Mariner, T. A. Waldmann, and Y. Tagaya. 2002. IL-15Rα recycles and presents IL-15 in trans to neighboring cells. Immunity 17: 537-547. (Pubitemid 35351500)
20. Koka, R., P. R. Burkett, M. Chien, S. Chai, F. Chan, J. P. Lodolce, D. L. Boone, and A. Ma. 2003. Interleukin (IL)-15Rα-deficient natural killer cells survive in normal but not IL-15Rα-deficient mice. J. Exp. Med. 197: 977-984.
21. Koka, R., P. Burkett, M. Chien, S. Chai, D. L. Boone, and A. Ma. 2004. Cutting edge: murine dendritic cells require IL-15Rαto prime NK cells. J. Immunol. 173: 3594-3598.
22. + bone marrow-derived cells. Blood 103: 988-994.
23. Kobayashi, H., S. Dubois, N. Sato, H. Sabzevari, Y. Sakai, T. A. Waldmann, and Y. Tagaya. 2005. Role of trans-cellular IL-15 presentation in the activation of NK cell-mediated killing, which leads to enhanced tumor immunosurveillance. Blood 105: 721-727. (Pubitemid 40070758)
24. Mortier, E., T. Woo, R. Advincula, S. Gozalo, and A. Ma. 2008. IL-15Rα chaperones IL-15 to stable dendritic cell membrane complexes that activate NK cells via trans presentation. J. Exp. Med. 205: 1213-1225.
25. Lucas, M., W. Schachterle, K. Oberle, P. Aichele, and A. Diefenbach. 2007. Dendritic cells prime natural killer cells by trans-presenting interleukin 15. Immunity 26: 503-517. (Pubitemid 46602996)
26. Leonard, W. J. 2001. Role of Jak kinases and STATs in cytokine signal transduction. Int. J. Hematol. 73: 271-277.
27. Hunt, A. E., F. V. Lali, J. D. Lord, B. H. Nelson, T. Miyazaki, K. J. Tracey, and B. M. Foxwell. 1999. Role of interleukin (IL)-2 receptor β-chain subdomains and Shc in p38 mitogen-activated protein (MAP) kinase and p54 MAP kinase (stress-activated protein kinase/c-Jun N-terminal kinase) activation. IL-2-driven proliferation is independent of p38 and p54 MAP kinase activation. J. Biol. Chem. 274: 7591-7597. (Pubitemid 129505057)
28. Gu, H., H. Maeda, J. J. Moon, J. D. Lord, M. Yoakim, B. H. Nelson, and B. G. Neel. 2000. New role for Shc in activation of the phosphatidylinositol 3-kinase/Akt pathway. Mol. Cell. Biol. 20: 7109-7120.
29. Ellery, J. M., and P. J. Nicholls. 2002. Alternate signalling pathways from the interleukin-2 receptor. Cytokine Growth Factor Rev. 13: 27-40. (Pubitemid 34436960)
30. Nakamura, Y., S. M. Russell, S. A. Mess, M. Friedmann, M. Erdos, C. Francois, Y. Jacques, S. Adelstein, and W. J. Leonard. 1994. Heterodimerization of the IL-2 receptor β- and γ-chain cytoplasmic domains is required for signalling. Nature 369: 330-333. (Pubitemid 24159545)
31. Zambricki, E., A. Shigeoka, H. Kishimoto, J. Sprent, S. Burakoff, C. Carpenter, E. Milford, and D. McKay. 2005. Signaling T-cell survival and death by IL-2 and IL-15. Am. J. Transplant. 5: 2623-2631. (Pubitemid 43920055)
32. DiSanto, J. P. 1997. Cytokines: shared receptors, distinct functions. Curr. Biol. 7: R424-R426.
33. Ma, A., D. L. Boone, and J. P. Lodolce. 2000. The pleiotropic functions of interleukin 15: not so interleukin 2-like after all. J. Exp. Med. 191: 753-756.
34. Waldmann, T. A., S. Dubois, and Y. Tagaya. 2001. Contrasting roles of IL-2 and IL-15 in the life and death of lymphocytes: implications for immunotherapy. Immunity 14: 105-110.
35. Chiossone, L., C. Vitale, F. Cottalasso, S. Moretti, B. Azzarone, L. Moretta, and M. C. Mingari. 2007. Molecular analysis of the methylprednisolone- mediated inhibition of NK-cell function: evidence for different susceptibility of IL-2- versus IL-15-activated NK cells. Blood 109: 3767-3775. (Pubitemid 46641727)
36. Sun, R., J. Fan, H. Wei, C. Zhang, and Z. Tian. 2003. Use of interleukin-15 for preparation of adherent NK cells from human peripheral blood: comparison with interleukin-2. J. Immunol. Methods 279: 79-90. (Pubitemid 37297492)
37. high T cells and its antitumor action. J. Immunol. 180: 2099-2106.
38. Cornish, G. H., L. V. Sinclair, and D. A. Cantrell. 2006. Differential regulation of T-cell growth by IL-2 and IL-15. Blood 108: 600-608.
39. Schumacher, T. N., and T. J. Tsomides. 2001. In vitro radiolabeling of peptides and proteins. In Current Protocols in Protein Science, Chap. 3: Unit 3 3.
40. Krutzik, P. O., and G. P. Nolan. 2003. Intracellular phospho-protein staining techniques for flow cytometry: monitoring single cell signaling events. Cytometry A 55: 61-70.
41. Bani, L., V. Pasquier, M. Kryworuchko, J. Salamero, and J. Theze. 2001. Unstimulated human CD4 lymphocytes express a cytoplasmic immature form of the common cytokine receptor γ-chain. J. Immunol. 167: 344-349. (Pubitemid 32567798)
42. Pillet, A. H., O. Juffroy, V. Mazard-Pasquier, J. L. Moreau, F. Gesbert, P. Chastagner, J. H. Colle, J. Theze, and T. Rose. 2008. Human IL-Rβ chains form IL-2 binding homodimers. Eur. Cytokine Netw. 19: 49-59.
43. Alter, G., J. M. Malenfant, and M. Altfeld. 2004. CD107a as a functional marker for the identification of natural killer cell activity. J. Immunol. Methods 294: 15-22. (Pubitemid 39626587)
44. David, D., L. Bani, J. L. Moreau, C. Demaison, K. Sun, O. Salvucci, T. Nakarai, M. de Montalembert, S. Chouaib, M. Joussemet, et al. 1998. Further analysis of interleukin-2 receptor subunit expression on the different human peripheral blood mononuclear cell subsets. Blood 91: 165-172. (Pubitemid 28018741)
45. Eckenberg, R., T. Rose, J. L. Moreau, R. Weil, F. Gesbert, S. Dubois, D. Tello, M. Bossus, H. Gras, A. Tartar, et al. 2000. The first α helix of interleukin (IL)-2 folds as a homotetramer, acts as an agonist of the IL-2 receptor β chain, and induces lymphokine-activated killer cells. J. Exp. Med. 191: 529-540.
46. Rose, T., J. L. Moreau, R. Eckenberg, and J. Theze. 2003. Structural analysis and modeling of a synthetic interleukin-2 mimetic and its interleukin-2Rβ2 receptor. J. Biol. Chem. 278: 22868-22876. (Pubitemid 36830350)
47. 2-microglobulin-transfected Daudi cells. J. Immunol. 141: 17-20.
48. Yang, M., S. Omura, J. S. Bonifacino, and A. M. Weissman. 1998. Novel aspects of degradation of T cell receptor subunits from the endoplasmic reticulum (ER) in T cells: importance of oligosaccharide processing, ubiquitination, and proteasome-dependent removal from ER membranes. J. Exp. Med. 187: 835-846. (Pubitemid 28141657)
49. Mortier, E., J. Bernard, A. Plet, and Y. Jacques. 2004. Natural, proteolytic release of a soluble form of human IL-15 receptor α-chain that behaves as a specific, high affinity IL-15 antagonist. J. Immunol. 173: 1681-1688. (Pubitemid 38971599)
50. Bulanova, E., V. Budagian, E. Duitman, Z. Orinska, H. Krause, R. Ruckert, N. Reiling, and S. Bulfone-Paus. 2007. Soluble Interleukin IL-15Rα is generated by alternative splicing or proteolytic cleavage and forms functional complexes with IL-15. J. Biol. Chem. 282: 13167-13179. (Pubitemid 47100509)
51. Waldmann, T. A. 2004. Targeting the interleukin-15/interleukin-15 receptor system in inflammatory autoimmune diseases. Arthritis Res. Ther. 6: 174-177.
52. Silva, M. A., J. Menezes, C. Deslandres, and E. G. Seidman. 2005. Anti-inflammatory role of interleukin-15 in Crohn's disease. Inflamm. Bowel Dis. 11: 219-230. (Pubitemid 40439676)
53. Kumaki, S., R. Armitage, M. Ahdieh, L. Park, and D. Cosman. 1996. Interleukin- 15 up-regulates interleukin-2 receptor α chain but down-regulates its own high-affinity binding sites on human T and B cells. Eur. J. Immunol. 26: 1235-1239. (Pubitemid 126487436)
54. Park, J. H., Q. Yu, B. Erman, J. S. Appelbaum, D. Montoya-Durango, H. L. Grimes, and A. Singer. 2004. Suppression of IL7Rα transcription by IL-7 and other prosurvival cytokines: a novel mechanism for maximizing IL-7-dependent T cell survival. Immunity 21: 289-302.
55. Carson, W. E., M. E. Ross, R. A. Baiocchi, M. J. Marien, N. Boiani, K. Grabstein, and M. A. Caligiuri. 1995. Endogenous production of interleukin 15 by activated human monocytes is critical for optimal production of interferon-γ by natural killer cells in vitro. J. Clin. Invest. 96: 2578-2582.
56. Granucci, F., I. Zanoni, and P. Ricciardi-Castagnoli. 2008. Central role of dendritic cells in the regulation and deregulation of immune responses. Cell Mol. Life Sci. 65: 1683-1697.
57. Granucci, F., S. Feau, V. Angeli, F. Trottein, and P. Ricciardi-Castagnoli. 2003. Early IL-2 production by mouse dendritic cells is the result of microbial-induced priming. J. Immunol. 170: 5075-5081. (Pubitemid 36554737)
58. Marcenaro, E., B. Ferranti, M. Falco, L. Moretta, and A. Moretta. 2008. Human NK cells directly recognize Mycobacterium bovis via TLR2 and acquire the ability to kill monocyte-derived DC. Int. Immunol. 20: 1155-1167.